3 Large Caps that Analysts Suggest to Buy
CLSA has outperform rating but cut FY17-19 earnings by 1-2 percent and target to Rs 1120 from Rs 1200 per share.
Morgan Stanley lowered FY17-19 EPS estimates by 2.9-3.6 percent and target cut to Rs 1150 per share. It says ramp-down of RBS contract & increased uncertainty to weigh on growth. It forecast dollar revenue growth of 9.2 percent YoY in FY17. It has also cut EBIT margin target for FY17 to 24.5 percent from 25 percent.
Macquarie maintains outperform rating with target increased to Rs 600 from Rs 535 per share on its firm Q1 numbers. It expects JLR to register strong volume growth over FY16-18 led by new models.
CLSA reiterates buy rating with target increased to Rs 635 from Rs 545 per share. It says forex losses impact JLR’s margins but should bounce back. It expects a strong rebound in JLR’s margins in balance FY17 & FY18 and a strong 21 percent EPS CAGR over FY16-19.
Credit Suisse maintains underperform as stock is already at 22 times FY18 EPS. It expects case credit with respect to Aloxi by September/October.